Behavioral factors associated with HCV and HIV co-infection in residents of São Paulo, Brazil
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Behavioral factors associated with HCV and HIV co-infection in residents of São Paulo, Brazil ; volume:9 ; number:1 ; day:25 ; month:5 ; year:2012 ; pages:1 ; date:12.2012
Retrovirology ; 9, Heft 1 (25.5.2012), 1, 12.2012
- Urheber
-
Farias, Norma
- Beteiligte Personen und Organisationen
-
de Oliveira, Umbeliana Barbosa
de Souza, Iára
Moraes Coelho, Débora
Afonso Binelli, Claudia
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S1-P130
- URN
-
urn:nbn:de:1111-2016080723918
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Farias, Norma
- de Oliveira, Umbeliana Barbosa
- de Souza, Iára
- Moraes Coelho, Débora
- Afonso Binelli, Claudia
- SpringerLink (Online service)
Ähnliche Objekte (12)
HIV-HCV Co-infection Among Blood Donors
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
HIV-HCV Co-infection Among Blood Donors
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
HIV-HCV Co-infection Among Blood Donors
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review